unknown
Stage
1
Investors
About
Cortexyme is a clinical-stage pharmaceutical company developing oral therapeutics to treat Alzheimer's disease and other degenerative diseases by targeting bacterial proteases implicated in disease progression.
Explore Cortexyme's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.